We can't find the internet
Attempting to reconnect
44271.1 IP-LS
44271.1 IP-LS
Résumé
EZH2 Inhibitors: a new treatment opportunity with disease modifying potential for people with hereditary blindness
Textes supplémentaires
Abstract
No generic treatments are available for inherited retinal dystrophies resulting in blindness. We found that the inhibition of an enzyme involved in epigenetic modifications markedly improved cell survival, so we aim to determine the best existing drug to delay blindness in human in the near future.
Participants
Yvan Arsenijevic
Kontaktperson
yvan.arsenijevic@fa2.ch
Fondation Asile des aveugles Yvan Arsenijevic Av. de France 15 1004 Lausanne VD CH
Détails du projet
- Office de recherche
- INNOSUISSE
- Statut du projet
- Abgeschlossen
- Type de projet
- Forschungsprojekt
- Date de début
- 2020-05-31
- Date de fin
- 2022-03-31
- Coûts totaux approuvés
- CHF 356229.26
- Section
- 60 Life Sciences
- Domaine politique NABS
- Industrielle Produktivität und Technologie
Disciplines de recherche
- T410 Pharmaceuticals and related technologies 100.0%